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Introduction
Acute intestinal obstruction occurs in 7-30% of patients
with colorectal carcinoma, especially if tumour is located
at or distal to the splenic flexure. Traditionally, emer-
gency surgical decompression is the treatment option,
with the resection of obstructing tumour and often with
the creation of defunctioning stoma. Emergency surgical
decompression is very effective, but it is associated to
high mortality rate, depending on patients comorbidities,
anaesthetic and emergency surgery risks. Moreover
stoma causes high morbidity rate and a worsening in
quality of life, with up to 60% patients that would never
be reversed [1].
An alternative to surgery is intraluminal colorectal
stenting, first described by Dohmoto in 1991 in 19
patients with non-resectable metastatic rectal cancer. In
1993 Tejero used metallic stents in patients with colon
obstruction as “bridge to surgery” [2].
Since its introduction self-expandable metal stent
(SEMS) has increasingly been used for malignant colon
obstruction and several studies showed its efficacy in
relieving the obstruction offering good palliation, and,
whenever possible, avoiding emergency surgery and
facilitating single-stage surgery, reducing stoma creation.
Colonic stenting is also associated to complications, as
intestinal perforation, stent migration and clinical
failure.
Nowadays there is debate concerning five-years survi-
val and cancer-specific mortality: it seems that five-years
survival is lower and cancer-specific mortality is higher
in SEMS patients compared to urgent surgery patients,
because of delayed surgery [3].
The aim of the study was to review our experience
and assess the effectiveness of colonic stenting in
malignant colon obstruction, as a “bridge to surgery” or
as a palliative treatment, in terms of safety, efficacy and
clinical outcomes.
Methods
During the studied period (2008-2013), 18 patients over
80 were selected to undergo endoscopic stenting for
malignant colon obstruction in L. Sacco University Hos-
pital, Milan.
The main indication for stenting was obstructive colon
cancer, diagnosed by clinical evaluation, abdomen x-rays
and CT-scan. Exclusion criteria were perforation, perito-
nitis or intestinal bleeding.
According to the characteristics of the stricture stents
with different length (140, 110, 100 mm) and diameter
(22, 24 mm) were placed. In case of palliative treatment,
covered stents were preferred. All the stents were placed
under endoscopic and fluoroscopic guide.
After 24 hours from stent insertion, an abdominal x-
ray was obtained routinely.
Technical success of the procedure was defined as the
right placement of the stent across the stricture; clinical
success was defined as colonic decompression and relief
of obstructive symptoms within 96 hours from the
procedure.
In the group “bridge to surgery”, the interval between
stent placement and elective surgery was decided
according to clinical conditions and bowel function of
the patient.
Results
These are preliminary results of a study conducted on a
total of 18 patients (mean age 83,4 years, range 80-100,
12 men, 7 women). The procedure was performed as a
bridge to surgery in 8 patients (44,5%, mean age 80,6)
and for palliative management in 10 patients (55,5%,
mean age 85,0).
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The site of obstruction was in transverse colon in 1
patient (5,6%), left colon in 3 patients (16,7%), rectosig-
moid in 14 patients (77,8%).
Technical success was obtained in 15 patients (83,3%);
failure occurred in 3 patients (16,7%), 2 in the “bridge
to surgery” group and 1 in palliation group. Failure was
due to perforation during the procedure (n=1), a nar-
rowing stricture (n=1) and incomplete stent expansion
(n=1).
Clinical success was obtained in all the 15 patients
with successful stent placement, within the first day
after the procedure, except in one case in which
occurred after 4 days.
Early complications (within the first week after stent
placement) occurred in 4 patients (22,2%), 3 in the
“bridge to surgery group” and 1 in the palliation group.
Early complications were 2 cases of intestinal bleeding
and 1 case of micro-perforation, conservatively treated,
and 1 case of rectal perforation that required emergency
surgery. There were no cases of stent obstruction,
migration or rectal tenesmus.
After the first week, no complications were recorded.
In the group of “bridge to surgery” 6 patients under-
went elective surgery (75%) without the need of stoma
creation. Median time between stent placement and
elective surgery was 8,7 days (range 3-13).
In the case of rectal perforation, a subtotal colectomy
with diverting ileostomy was performed; the patient
with narrowing stricture underwent emergency Hart-
mann procedure.
Conclusions
Colonic endoscopic stenting is safe and effective in the
management of malignant colorectal obstruction for pal-
liative care or “bridge to a surgery”, with a low compli-
cation rate (22,2%).
In the “bridge to surgery” group, stent placement is an
option to improve clinical conditions and decrease
bowel dilatation before elective surgery. These make
colonic stenting a good alternative treatment to emer-
gency colostomy or Hartmann procedure.
Moreover it provides a good long-term palliation,
without the need of surgical procedure and stoma crea-
tion, with an improvement in the quality of life.
Our promising preliminary results about colonic stent-
ing in elderly patients should be confirmed by a pro-
spective randomized trial on a higher number of
patients.
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